The precise mechanism for the anti-obesity effect of MetAP2 inhibitors is not clear but the ability of MetAP2 to suppress activity of extracellular signal regulated kinases 1 and 2 (ERK1/2) represents one of the key mechanisms for the observed anti-obesity effect (128). The gene discussed is METAP2; the disease is obesity due to melanocortin 4 receptor deficiency.